Shattuck Labs, Inc. (STTK) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $10.00K; Additional Paid in CapitalUSD $671.64M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-63.00K; Retained Earnings (Accumulated Deficit)USD $-460.45M.
- 2026-03-31: Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $541.12M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $0.00; Retained Earnings (Accumulated Deficit)USD $-445.30M.
- 2025-12-31: Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $512.91M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $6.00K; Retained Earnings (Accumulated Deficit)USD $-430.53M.
- 2025-09-30: Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $511.17M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $3.00K; Retained Earnings (Accumulated Deficit)USD $-417.94M.
Shattuck Labs, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.00K | $671.64M | $-63.00K | $-460.45M | $211.14M | (m) | 3 month · $2.73M |
| 2026-03-31 | $7.00K | $541.12M | $0.00 | $-445.30M | $95.83M | (m) | 3 month · $2.42M |
| 2025-12-31 | $7.00K | $512.91M | $6.00K | $-430.53M | $82.39M | (m) | 12 month · $7.00M |
| 2025-09-30 | $7.00K | $511.17M | $3.00K | $-417.94M | $93.24M | (m) | 3 month · $1.78M |
| 2025-06-30 | $5.00K | $464.89M | $1.00K | $-407.88M | $57.02M | (m) | 3 month · $1.89M |
| 2025-03-31 | $5.00K | $463.00M | $0.00 | $-395.42M | $67.59M | (m) | 3 month · $1.72M |
| 2024-12-31 | $5.00K | $461.34M | $2.00K | $-381.72M | $79.63M | 12 month · $17.00K | 12 month · $9.55M |
| 2024-09-30 | $5.00K | $459.56M | $52.00K | $-363.04M | $96.58M | 3 month · $0.00 | 3 month · $2.56M |
| 2024-06-30 | $5.00K | $456.98M | $-5.00K | $-346.37M | $110.62M | (m) | 3 month · $2.67M |
| 2024-03-31 | $5.00K | $453.64M | $-14.00K | $-324.81M | $128.81M | 3 month · $17.00K | 3 month · $2.48M |
| 2023-12-31 | $5.00K | $451.01M | $4.00K | $-306.31M | $144.71M | (m) | 12 month · $6.94M |
| 2023-09-30 | $5.00K | $401.39M | $7.00K | $-288.62M | $112.78M | (m) | 3 month · $1.76M |
| 2023-06-30 | $5.00K | $399.61M | $-74.00K | $-261.08M | $138.46M | (m) | 3 month · $1.85M |
| 2023-03-31 | $5.00K | $397.72M | $-339.00K | $-239.74M | $157.65M | (m) | 3 month · $1.68M |
| 2022-12-31 | $5.00K | $396.04M | $-877.00K | $-219.01M | $176.16M | (m) | 12 month · $6.46M |
| 2022-09-30 | $5.00K | $394.35M | $-1.33M | $-193.60M | $199.42M | (m) | 3 month · $1.72M |
| 2022-06-30 | $5.00K | $392.60M | $-1.11M | $-168.97M | $222.53M | (m) | 3 month · $1.53M |
| 2022-03-31 | $5.00K | $391.06M | $-527.00K | $-141.59M | $248.94M | (m) | 3 month · $1.51M |
| 2021-12-31 | $5.00K | $389.41M | $-560.00K | $-117.07M | $271.79M | (m) | 12 month · $5.47M |
| 2021-09-30 | $5.00K | $387.90M | $-1.83M | $-124.91M | $261.17M | (m) | 3 month · $1.34M |
| 2021-06-30 | $5.00K | $386.21M | $-1.62M | $-107.50M | $277.09M | (m) | 3 month · $1.73M |
| 2021-03-31 | $5.00K | $383.22M | $-660.00K | $-83.91M | $298.66M | (m) | 3 month · $1.18M |
| 2020-12-31 | $5.00K | $382.01M | $-63.00K | $-72.09M | $309.86M | (m) | 12 month · $1.27M |
| 2020-09-30 | $1.00K | $1.73M | $-10.00K | $-60.08M | $-58.36M | (m) | 3 month · $312.00K |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-47.03M | (m) | 3 month · $137.00K |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-40.86M | (m) | 3 month · $180.00K |
| 2019-12-31 | $1.00K | $887.00K | $54.00K | $-35.49M | $-34.55M | (m) | 12 month · $461.00K |
| 2019-09-30 | (m) | (m) | (m) | (m) | $-27.28M | (m) | 3 month · $144.00K |
| 2019-06-30 | (m) | (m) | (m) | (m) | $-20.15M | (m) | 3 month · $87.00K |
| 2019-03-31 | (m) | (m) | (m) | (m) | $-14.42M | (m) | 3 month · $66.00K |
| 2018-12-31 | (m) | (m) | (m) | (m) | $-11.08M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |